全文获取类型
收费全文 | 28796篇 |
免费 | 1854篇 |
国内免费 | 87篇 |
专业分类
耳鼻咽喉 | 186篇 |
儿科学 | 929篇 |
妇产科学 | 792篇 |
基础医学 | 4489篇 |
口腔科学 | 355篇 |
临床医学 | 2575篇 |
内科学 | 6510篇 |
皮肤病学 | 402篇 |
神经病学 | 2779篇 |
特种医学 | 981篇 |
外国民族医学 | 5篇 |
外科学 | 4608篇 |
综合类 | 289篇 |
一般理论 | 10篇 |
预防医学 | 1714篇 |
眼科学 | 293篇 |
药学 | 1657篇 |
中国医学 | 33篇 |
肿瘤学 | 2130篇 |
出版年
2023年 | 100篇 |
2022年 | 177篇 |
2021年 | 401篇 |
2020年 | 231篇 |
2019年 | 404篇 |
2018年 | 518篇 |
2017年 | 355篇 |
2016年 | 417篇 |
2015年 | 540篇 |
2014年 | 719篇 |
2013年 | 1002篇 |
2012年 | 1547篇 |
2011年 | 1727篇 |
2010年 | 1060篇 |
2009年 | 1018篇 |
2008年 | 1632篇 |
2007年 | 1644篇 |
2006年 | 1661篇 |
2005年 | 1792篇 |
2004年 | 1566篇 |
2003年 | 1522篇 |
2002年 | 1546篇 |
2001年 | 593篇 |
2000年 | 614篇 |
1999年 | 545篇 |
1998年 | 422篇 |
1997年 | 373篇 |
1996年 | 329篇 |
1995年 | 306篇 |
1994年 | 286篇 |
1993年 | 268篇 |
1992年 | 428篇 |
1991年 | 366篇 |
1990年 | 339篇 |
1989年 | 362篇 |
1988年 | 325篇 |
1987年 | 308篇 |
1986年 | 282篇 |
1985年 | 273篇 |
1984年 | 257篇 |
1983年 | 210篇 |
1982年 | 172篇 |
1981年 | 187篇 |
1980年 | 108篇 |
1979年 | 193篇 |
1978年 | 146篇 |
1976年 | 105篇 |
1975年 | 103篇 |
1974年 | 125篇 |
1973年 | 115篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
52.
Hans Bosma Martin PJ van Boxtel Gertrudis IJM Kempen Jacques ThM van Eijk Jelle Jolles 《BMC public health》2007,7(1):179
Background
The aims of this study were to examine the extent to which higher intellectual abilities protect higher socio-economic groups from functional decline and to examine whether the contribution of intellectual abilities is independent of childhood deprivation and low birth weight and other socio-economic and developmental factors in early life. 相似文献53.
A M Bougerolle J L Chabard M Jbilou G Dordain A Eschalier O Aumaitre J Gaillot J J Piron J Petit J A Berger 《European journal of drug metabolism and pharmacokinetics》1989,14(2):139-144
The bioavailability of two oral formulations of trimipramine, tablets and solution, was performed in twelve healthy volunteers, in a cross-over study. Each formulation was administered in the morning after a fasted period, and in the evening after a meal, in order to evaluate the role of both administration time and food consumption on the plasma kinetic parameters, under usual therapeutic conditions. A high interindividual variability of data was found. First, the extent of bioavailability was identical for the two formulations but the rate of bioavailability seemed to be different, with the p.o. solution, being more rapidly absorbed (tmax = 1.50 h). The effect of administration time was more obvious for the solution as shown by a lower quantitative absorption as well as a delay in time to reach the maximal concentration. Regardless of formulation and administration time, the t1/2 beta was about 10 hours and the mean MRT value was 11 hours. 相似文献
54.
Margaretha Jennerwein Ronald Gust Richard Müller Helmut Schnenberger Jürgen Engel Martin R. Berger Dietrich Schmhl Siegfried Seeber Reinhanidt Osieka Ghanem Atassi Danile Marchal-De Bock 《Archiv der Pharmazie》1989,322(2):67-73
The activity of stereoisomeric [1,2-bis(3-hydroxyphenyl)ethylenediamine] dichloroplatinum(II)-complexes (1-PtCl2,R,S; 2-PtCl2, R,R/S,S; 3-PtCl2, R,R; 4-PtCl2, S,S) on several tumor models (MDA-MB 231 breast cancer cell line; P 388 leukemia, mouse; L 1210 leukemia, mouse; L 5222 leukemia, rat; Ehrlich ascites tumor, mouse--wildtype; cisplatin-, etoposide-, cyclophosphamide-, and daunomycin-resistant, resp.) is described. For comparison the analogous [1,2-bis(4-hydroxyphenyl)ethylendiamine]dichloroplatinum (II)-complexes (5-PtCl2, R, S; 6-PtCl2, R,R/S,S; 7-PtCl2, R,R; 8-PtCl2, S,S) and cisplatin are used. 1-PtCl2 to 4-PtCl2 (OH in 3,3'-positions) show their maximum antitumor effect at lower doses than 5-PtCl2 to 8-PtCl2 (OH in 4,4'-positions). 2-PtCl2 and 6-PtCl2 (R,R/S,S) are more active than 1-PtCl2 and 5-PtCl2 (R,S). 4-PtCl2 and 8-PtCl2 (S,S) are superior to 3-PtCl2 and 7-PtCl2 (R,R). On the L 5222 leukemia 2-PtCl2 (R,R/S,S), 4-PtCl2 (S,S) and 8-PtCl2 (S,S) markedly surpass cisplatin. Strong effects are produced by 2-PtCl2 to 4-PtCl2 on the Ehrlich ascites tumor (wildtype, cisplatin-, etoposide-, cyclophosphamide-, and daunomycin-resistant, resp.). The combination of 4-PtCl2 with cisplatin results in a weakly synergistic effect. 相似文献
55.
Martine Hascoët Michel Bourin Jacques Bradwejn 《Progress in neuro-psychopharmacology & biological psychiatry》1991,15(6):825-840
1. The mechanism of action of drugs might change according to the test used. Several noradrenergic drugs were tested in order to understand their implication in the mobility tests.
2. It was found that clonidine, an Alpha 2 agonist, acted differently according to the tast used. It provoked sedation in spontaneous activity test, and anti-immobility effects in the other tests.
3. Tall suspension test is able to show the double acting of clonidine.
4. Idazoxan might act either as an alpha 2 antagonist or as partial alpha 2 agonist. TST shown the unexpected partial alpha agonist effect of the molecule.
5. Forced swimming test is more specific for predicting antidepressant activity than tail suspension test which is close to a spontaneous activity model. 相似文献
56.
57.
Jacques Frey 《Clinical chemistry and laboratory medicine》2004,42(1):9-12
The relationship between ageing and nutrition is considered with collagen as the intermediate target. Some data showed that diet restriction resulted in decreased collagen accumulation and collagen ageing. Conversely, being overweight reduced the lifespan and increased collagen ageing. Collagen ageing, which includes low turnover and glycoxidation, involves an increase in both stiffness and weakness. Their consequences concern all tissues including those with vital importance such as cartilage, heart ventricle or arterial wall. 相似文献
58.
59.
J Brent Richards William D Leslie Lawrence Joseph Kerry Siminoski David A Hanley Jonathan D Adachi Jacques P Brown Suzanne Morin Alexandra Papaioannou Robert G Josse Jerilynn C Prior K Shawn Davison Alan Tenenhouse David Goltzman 《Journal of bone and mineral research》2007,22(2):228-234
The impact of clinical risk factor-based absolute risk methods on the prevalence of high risk for osteoporotic fracture is unknown. We applied absolute risk methods to 6646 subjects and found that the prevalence of elderly women deemed to be at high risk increased substantially, whereas the overall prevalence was highly dependent on the threshold used to designate high risk. INTRODUCTION: Many groups have advocated using absolute risk methods that incorporate clinical risk factors to target patients for osteoporosis therapy. We examined how the application of such absolute risk classification systems influences the prevalence of those considered to be at high risk for osteoporotic fracture and compared these systems to one based solely on BMD. MATERIALS AND METHODS: Using 6646 subjects from the Canadian Multicentre Osteoporosis Study (CaMos), a prospective, randomly selected, population-based cohort, we assessed three different systems for determining prevalence of high risk for osteoporotic fracture: a BMD-based system; a simplified risk factor system incorporating age, sex, BMD, and two clinical risk factors; and a comprehensive system, incorporating age, sex, BMD, and seven clinical risk factors. The 10-year absolute risks of incident fragility fracture were compared across systems using three different high-risk thresholds. RESULTS: The prevalence of a T score < or = -2.5 was 18.8% (95% CI: 17.7-19.9%) in women and 3.9% (95% CI: 3.0-4.7%) in men. Using a 15% 10-year risk of fracture threshold, the prevalence of women at high risk increased to 46.9% (95% CI: 45.4-48.4) and 42.5% (95% CI: 41.1-43.9) when the comprehensive and simplified risk factor classification systems were used, respectively. Using a 25% 10-year absolute risk threshold, the prevalence of high risk was similar to that of the BMD-based system, whereas the 20% threshold gave intermediate rates. All thresholds analyzed resulted in an increased prevalence of older women at high risk for fracture, whereas only the 15% 10-year risk of fracture threshold resulted in an increase in the prevalence of men at high risk. CONCLUSIONS: The application of risk factor-based systems results in an increased prevalence of older women at high risk. The prevalence of individuals at high risk may increase with changes to the methods used to determine those who are eligible for therapy. These data have important implications for the pattern of care and costs of treating osteoporotic fractures. 相似文献
60.